Invesco Pharmaceuticals ETF
PJP
93 hedge funds and large institutions have $65.7M invested in Invesco Pharmaceuticals ETF in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 7 closing their positions.
198% more capital inflows, than outflows
Capital inflows: $15.8M | Capital outflows: $5.32M
129% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 7
8% more funds holding
Funds holding: 86 → 93 (+7)
2.98% more ownership
Funds ownership: 19.91% → 22.88% (+3%)
0% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$3.23M |
| 2 |
Morgan Stanley
New York
|
+$2.27M |
| 3 |
FGA
Fortis Group Advisors
Westwood,
New Jersey
|
+$2M |
| 4 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
+$1.05M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$820K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRI
Commonwealth Retirement Investments
Richmond,
Virginia
|
-$1.56M |
| 2 |
JGCM
Joseph Group Capital Management
Columbus,
Ohio
|
-$1.25M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$845K |
| 4 |
EH
Equitable Holdings
New York
|
-$243K |
| 5 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$219K |
PJP Hedge Fund Activity: Q1 2024 in Review
93 of the 6,963 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2024, worth a combined $65.7M — up 25% from $52.6M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new PJP positions and 7 closed out — a net gain of 9 holders — while 24 added to existing stakes and 24 trimmed.
The largest buyer was LPL Financial, adding an estimated $3.23M. The largest seller was Commonwealth Retirement Investments, exiting entirely with an estimated $1.56M sold.
- 93 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2024, up from 86 in Q4 2023.
- Funds reported $65.7M of Invesco Pharmaceuticals ETF stock for Q1 2024, up 25% quarter-over-quarter.
- 16 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2024 and 7 closed out, a net change of +9 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2024 was LPL Financial, an estimated $3.23M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2024 was Commonwealth Retirement Investments, an estimated $1.56M sold.
Based on aggregated 13F filings for Q1 2024.